SGLT2 inhibitors as potentially helpful drugs in PI3K inhibitor-induced diabetes: a case report
{{output}}
Background: Hyperglycemia is the most common side-effect of phosphatidylinositol 3-kinase (PI3K) inhibitors that are approved for the treatment of some advanced or metastatic breast cancers. This side-effect is likely due to the ... ...
